Siga Technologies (SIGA) Net Income (2010 - 2025)
Siga Technologies' (SIGA) quarterly Net Income came in at -$6.4 million in Q3 2025, down 573.67% on a YoY basis from $1.3 million in Q3 2024, and down 117.95% quarter-over-quarter from $35.5 million in Q2 2025.
Analysis
Siga Technologies (SIGA) Net Income (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Net Income for 16 consecutive years, with -$6.4 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Net Income fell 573.67% year-over-year to -$6.4 million; the trailing twelve-month figure through Sep 2025 stood at $74.5 million (down 7.89% YoY), and the FY2024 full-year result was $59.2 million, down 6.41% from the prior year.
- Net Income retreated to -$6.4 million in Q3 2025 per SIGA's latest filing, from $35.5 million in the prior quarter.
- Across five years, Net Income topped out at $73.2 million in Q4 2021 and bottomed at -$6.4 million in Q3 2025.
- Historically, Net Income has averaged $13.2 million across 5 years, with a median of $167606.0 in 2021.
- The widest YoY moves for Net Income: up 1873.05% in 2025, down 573.67% in 2025.
- Over 5 years, Net Income stood at $73.2 million in 2021, then sank by 106.34% to -$4.6 million in 2022, then soared by 1553.97% to $67.5 million in 2023, then sank by 32.16% to $45.8 million in 2024, then tumbled by 113.91% to -$6.4 million in 2025.
- According to Business Quant data, Net Income over the past three periods registered -$6.4 million, $35.5 million, and -$370415.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -238.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 2.16 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | -644.37 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 585.61 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 333.00 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -6.37 Mn |
| Jun 30, 2025 | 35.47 Mn |
| Mar 31, 2025 | -370,415.00 |
| Dec 31, 2024 | 45.76 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 10.28 Mn |
| Dec 31, 2023 | 67.46 Mn |
| Sep 30, 2023 | -393,066.00 |
| Jun 30, 2023 | -2.85 Mn |
| Mar 31, 2023 | -917,677.00 |
| Dec 31, 2022 | -4.64 Mn |
| Sep 30, 2022 | 33.03 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | -361,049.00 |
| Dec 31, 2021 | 73.21 Mn |
| Sep 30, 2021 | -3.08 Mn |
| Jun 30, 2021 | 167,606.00 |
| Mar 31, 2021 | -812,105.00 |
| Dec 31, 2020 | 20.18 Mn |